112 related articles for article (PubMed ID: 2981643)
1. Fluoro-substituted N-nitrosamines. 7. Non-genotoxic N-nitroso-bis(2,2,2-trifluoroethyl)amine and N-nitroso-bis(2,2,3,3,4,4,4-heptafluorobutyl)amine: binding to cytochrome P-450, acidity of alpha-protons and pharmacokinetic investigations.
Janzowski C; Gottfried J; Preussmann R; Eisenbrand G
Carcinogenesis; 1985 Jan; 6(1):79-84. PubMed ID: 2981643
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluorination on in-vitro metabolism and biological activity of N-nitrosodialkylamines.
Janzowski C; Eisenbrand G; Gottfried J; Preussmann R
IARC Sci Publ; 1984; (57):553-8. PubMed ID: 6533047
[TBL] [Abstract][Full Text] [Related]
3. Fluoro-substituted N-nitrosamines. 3. Microsomal metabolism of N-nitrosodibutylamine and of fluorinated analogs.
Janzowski C; Gottfried J; Eisenbrand G; Preussman R
Carcinogenesis; 1982; 3(7):777-80. PubMed ID: 7116573
[TBL] [Abstract][Full Text] [Related]
4. Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat.
Gottfried-Anacker J; Preussmann R; Eisenbrand G; Janzowski C
Carcinogenesis; 1985 Nov; 6(11):1559-64. PubMed ID: 4053275
[TBL] [Abstract][Full Text] [Related]
5. In-vitro metabolism of fluorinated diakylnitrosamines.
Janzowski C; Gottfried J; Pool BL; Eisenbrand G; Preussmann R
IARC Sci Publ; 1982; (41):517-24. PubMed ID: 7141558
[TBL] [Abstract][Full Text] [Related]
6. Fluoro-substituted N-nitrosamines. 2. Metabolism of N-nitrosodiethylamine and of fluorinated analogs in liver microsomal fractions.
Janzowski C; Pool BL; Preussmann R; Eisenbrand G
Carcinogenesis; 1982; 3(2):155-9. PubMed ID: 7067043
[TBL] [Abstract][Full Text] [Related]
7. Fluoro-substituted N-nitrosamines. 4. Comparative genotoxic activities of N-nitrosodibutylamine and three fluorinated analogues in two bacterial systems.
Pool BL; Janzowski C; Eisenbrand G; Preussmann R
Carcinogenesis; 1982; 3(7):781-4. PubMed ID: 6749319
[TBL] [Abstract][Full Text] [Related]
8. Fluoro-substituted N-nitrosamines. 5. Carcinogenicity of n-nitroso-bis-(4,4,4-trifluoro-n-butyl)amine in rats.
Preussmann R; Habs M; Habs H; Stummeyer D
Carcinogenesis; 1982; 3(10):1219-22. PubMed ID: 7172421
[TBL] [Abstract][Full Text] [Related]
9. Investigations on organ-specific metabolism and genotoxic effects of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine (BCPN) and its analogs N-nitrosodibutylamine (NDBA) and N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA).
Janzowski C; Jacob D; Henn I; Zankl H; Poole-Zobel BL; Eisenbrand G
Toxicology; 1989 Dec; 59(2):195-209. PubMed ID: 2588266
[TBL] [Abstract][Full Text] [Related]
10. Intestinal metabolism of nitrosamines. 1. Transport and metabolism of six nitrosamines in isolated perfused rat small intestinal segments.
Richter E; Richter-Cooberg U; Feng X; Schulze J; Wiessler M
Carcinogenesis; 1986 Jul; 7(7):1207-13. PubMed ID: 3087650
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate of omega-1 and omega-2 oxidized N-nitrosodibutylamines in the rat.
Suzuki E; Okada M
Jpn J Cancer Res; 1985 Mar; 76(3):173-83. PubMed ID: 3922835
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes.
Bellec G; Dréano Y; Bail JP; Ménez JF; Berthou F
Mutat Res; 1997 Jul; 377(2):199-209. PubMed ID: 9247615
[TBL] [Abstract][Full Text] [Related]
14. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
Yamazaki H; Oda Y; Funae Y; Imaoka S; Inui Y; Guengerich FP; Shimada T
Carcinogenesis; 1992 Jun; 13(6):979-85. PubMed ID: 1600620
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.
Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T
Carcinogenesis; 2000 Jun; 21(6):1227-32. PubMed ID: 10837014
[TBL] [Abstract][Full Text] [Related]
16. Hydroxylation of dibutylnitrosamine in the human liver and intestinal microsomal fractions.
Pacifici GM; Richter E; Lehmann G; Wiessler M; Zwickenpflug W; Giuliani L
Arch Toxicol; 1986 Feb; 58(3):196-8. PubMed ID: 3964084
[TBL] [Abstract][Full Text] [Related]
17. Fluoro-substituted N-nitrosamines. 1. Inactivity of N-nitrosobis(2,2,2-trifluoroethyl)amine in carcinogenicity and mutagenicity tests.
Preussmann R; Habs M; Pool B; Stummeyer D; Lijinsky W; Reuber MD
Carcinogenesis; 1981; 2(8):753-6. PubMed ID: 7026079
[TBL] [Abstract][Full Text] [Related]
18. Fluoro-substituted N-nitrosamines. 6. carcinogenicity of N-nitroso-(2,2,2-trifluoroethyl)-ethylamine in rats.
Preussmann R; Habs M; Habs H; Stummeyer D
Carcinogenesis; 1983; 4(6):755-7. PubMed ID: 6861279
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolites of N-nitrosodibutylamine in the rat: identification of N-acetyl-S-butyl-L-cysteine derivatives.
Suzuki E; Osabe M; Okada M; Ishizaka T; Suzuki T
IARC Sci Publ; 1987; (84):153-5. PubMed ID: 3679356
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
